Latest news about bitcoin, ethereum, blockchain, mining, cryptocurrency prices and more
Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
ANV600 combines a non-blocking αPD-1 antibody and an IL-2Rβ/γ selective agonist targeting IL-2 to tumor-specific …